Advancements in manufacturing technologies is a key driver driving nucleic acid therapeutics CDMO market revenue growth.

No longer a mere assistant who carries out the commands of DNA, RNA takes the lead in emerging therapeutics.

Look inside a brain cell with Huntington's disease or ALS and you are likely to find RNA clumped together. These solid-like clusters, thought to be irreversible, can act as sponges that soak up ...

New research has shown how harmful RNA clusters form in neurological disorders, and how they can be prevented and ...

Look inside a brain cell with Huntington's disease or ALS and you are likely to find RNA clumped together.These solid-like clusters ...

Imagine if you could "print" a tiny skyscraper using DNA instead of steel. That’s what researchers at Columbia and Brookhaven ...

When the Empire State Building was constructed, its 102 stories rose above midtown one piece at a time, with each individual ...

The Nucleic Acid Structure and Recognition Lab at Mayo Clinic studies DNA flexibility, novel DNA-RNA-based drug therapies and rare cancers.

Scientists just sequenced the first sea spider genome, uncovering genetic clues to limb growth, regeneration, and ancient ...

In this interview, Professor James J. Collins, founder of the field of Synthetic Biology, discusses his journey to founding ...

The Nucleic Acid Structure and Recognition Laboratory seeks to use RNA as the raw material for new kinds of gene regulators. These act by inhibiting or redirecting transcription factors. Taking a cue ...

The increasing incidence of genetic and rare diseases is a major factor driving revenue growth in the Antisense ...